On March 13, 2006, an unprecedented public-private partnership was launched to promote scientific and technical discussions on solutions for pediatric HIV treatment, formulations and access. This partnership includes innovator and generic pharmaceutical companies - the first time large numbers of both types of companies have participated in such a partnership -, civil society organizations such as Elizabeth Glaser Pediatric AIDS Foundation (EGPAF), and the United Nations system through UNAIDS, UNICEF and WHO, to work together with agencies across the USG to bring together a wide range of expertise, seeking to maximize the utility of currently available pediatric formulations and to accelerate children's access to treatment.
This partnership will complement other efforts of the President's Emergency Plan to support programs that expand treatment for adults and children, such as support for health care capacity-building and expedited regulatory review of drugs through HHS/FDA. The partnership will offer children and parents hope for a better day - the hope of families staying together, leading healthy lives, and living positively with HIV/AIDS.
| U.S. Government interagency website managed by the Office of U.S. Global AIDS Coordinator|
and the Bureau of Public Affairs, U.S. State Department.
External Link Policy | Copyright Information | Privacy | FOIA